Agafonov M,Volkova T,Kumeev R,Chibunova E,Terekhova I .2019 .Impact of pluronic F127 on aqueous solubility and membrane permeability of antirheumatic compounds of different structure and polarity. J. Mol. Liq, 274 : 770-777.
Alshehri S,Shakeel F,Ibrahim M,Elzayat E,Altamimi M,Shazly G,Mohsin K,Alkholief M,Alsulays B,Alshetaili A .2017 .Influence of the microwave technology on solid dispersions of mefenamic acid and flufenamic acid. PloS One, 12(7) : e0182011.
Barkat MA,Rizwanullah M,Beg S,Pottoo FH,Siddiqui S,Ahmad FJ .2019 .Paclitaxel-loaded nanolipidic carriers with improved oral bioavailability and anticancer activity against human liver carcinoma. AAPS PharmSciTech, 20(2) : 1-14.
Delijewski M and Haneczok J .2021 .AI drug discovery screening for COVID-19 reveals zafirlukast as a repurposing candidate. Med, 9 : 100077.
Drašković M,Medarević D,Aleksić I,Parojčić J .2017 .In vitro and in vivo investigation of tastemasking effectiveness of Eudragit E PO as drug particle coating agent in orally disintegrating tablets. Drug Dev, 43(5) : 723-731.
Feng Z,Li M,Wang W .2019 .Improvement of dissolution and tabletability of carbamazepine solid dispersions with high drug loading prepared by hotmelt extrusion. Pharmazie, 74(9) : 523-528.
Gajera BY,Dugar RP,Dave RH .2016 .Formulation development and optimization of ibuprofen poloxamer melt granules using hydrophilic excipients. J. Pharm. Res. Int., 13(6) : 1-19.
Huang S and Williams RO .2018 .Effects of the preparation process on the properties of amorphous solid dispersions. AAPS PharmSciTech, 19(5) : 1971-1984.
Kajdič S,Vrečer F,Kocbek P F .2018 .Preparation of poloxamer-based nanofibers for enhanced dissolution of carvedilol. Eur. J. Pharm. Sci., 117 : 331-340.
Kumar P,Agarwal A,Singh AK,Gautam AK,Chakraborti S,Kumar U,Kumar D,Bhattacharya B,Panda P,Saha B .2019 .Antineoplastic properties of zafirlukast against hepatocellular carcinoma via activation of mitochondrial mediated apoptosis. Regul, 109 : 104489.
Lei C,Wu S,Wen C,Li Y,Liu N,Huang J,Li L,Fu M,Liu J .2019 .Zafirlukast attenuates advanced glycation end-products (AGEs)-induced degradation of articular extracellular matrix (ECM). Int. Immunopharmacol., 68 : 68-73.
Madsen CM,Boyd B,Rades T,Müllertz A .2016 .Supersaturation of zafirlukast in fasted and fed state intestinal media with and without precipitation inhibitors. Eur. J. Pharm. Sci., 91 : 31-39.
McPherson S,Perrier J,Dunn C,Khadra I,Davidson S,Ainousah B,Wilson CG,Halbert G .2020 .Small scale design of experiment investigation of equilibrium solubility in simulated fasted and fed intestinal fluid. Eur. J. Pharm. Biopharm., 150 : 14-23.
Mehmood HQ,Faran SA,Chaudhry MA,Khalid SH,Khan IU,Hassan W,Ashfaq R,Asghar S R .2019 .An assessment of bioavailability of acrylate based pHsensitive complexes of lovastatin. Pak. J. Pharm. Sci., 32(Suppl) : 1129-1136.
Nanaki S,Eleftheriou RM,Barmpalexis P,Kostoglou M,Karavas E,Bikiaris D .2019 .Evaluation of dissolution enhancement of aprepitant drug in ternary pharmaceutical solid dispersions with Soluplus® and Poloxamer 188 prepared by melt mixing. Sci, 1(2) : 48.
Neeharika M and Jyothi BJ .2021 .Preparation and Evaluation of Zafirlukast Compression Coated Tablets for Chronotherapeutic Drug Delivery. J. Pharm. Res. Int., 33 : 154-166.
Porfiryeva NN,Nasibullin SF,Abdullina SG,Tukhbatullina IK,Moustafine RI,Khutoryanskiy VV .2019 .Acrylated Eudragit® E PO as a novel polymeric excipient with enhanced mucoadhesive properties for application in nasal drug delivery. Int. J. Pharm., 562 : 241-248.
Pradhan R,Kim SY,Yong CS,Kim JO .2016 .Preparation and characterization of spray-dried valsartan-loaded Eudragit® E PO solid dispersion microparticles. Asian J. Pharm. Sci., 11(6) : 744-750.
Rajasekhar D,Srinivasulu D,Sridhar C,Kumar GVN,Ramesh P .2016 .Synthesis, Spectral Characterization and Antioxidant Activity of Novel Zafirlukast Sulfonyl Derivatives. J. Chin. Chem. Soc., 63(3) : 267-274.
Saeed MA,Ansari MT,Ch BA .2019 .Enhancement of solubility and dissolution profile of artesunate by employing solid dispersion approach: An in-vitro evaluation. Pak. J. Pharm. Sci., 36(Suppl) : 353-361.
Schierle S,Flauaus C,Heitel P,Willems S,Schmidt J,Kaiser A,Weizel L,Goebel T,Kahnt AS,Geisslinger G .2018 .Boosting anti-inflammatory potency of zafirlukast by designed polypharmacology. J. Med, 61(13) : 5758-5764.
Sheng X,Tang J,Bao J,Shi X,Su W .2018 .Enhancement of in vitro dissolution and in vivo performance/oral absorption of FEB-poloxamer-TPGS solid dispersion. J. Drug Deliv. Sci. Technol, 46 : 408-415.
Shi N-Q,Zhang Y,Li Y,Lai H-W X,Feng B,Qi X-R .2017 .Self-micellizing solid dispersions enhance the properties and therapeutic potential of fenofibrate: Advantages, profiles and mechanisms. Int. J. Pharm., 528(1-2) : 563-577.
Song Q,Hu Z,Xie X,Cai H X .2020 .Zafirlukast prevented ox-LDL-induced formation of foam cells. Toxicol. Appl, 409 : 115295.
Tambe A,Pandita N A .2018 .Enhanced solubility and drug release profile of boswellic acid using a poloxamer-based solid dispersion technique. J. Drug Deliv. Sci. Technol, 44 : 172-180.
Thakral S,Terban MW,Thakral NK,Suryanarayanan R .2016 .Recent advances in the characterization of amorphous pharmaceuticals by X-ray diffractometry. Adv. Drug Deliv. Rev., 100 : 183-193.
Yadav B,Tanwar Y .2016 .Development, characterization and in vitro evaluation of flurbiprofen solid dispersions using polyethylene glycols as carrier. J. App. Pharm. Sci., 6(04) : 060-066.
Yang L,Chen X,Ni K,Li Y,Wu J,Chen W,Ji Y,Feng L,Li F,Chen D F .2020 .Proton-exchanged montmorillonite-mediated reactions of hetero-benzyl acetates: Application to the synthesis of Zafirlukast. , 61(29) : 152123.
Yoon I,Han H,Kim J .2018 .Successful management of refractory cough with the leukotriene receptor antagonist zafirlukast in a dog with chronic bronchitis: a case report. Vet, 63(4) : 181-186.
Zeng C,Wang D,Chen C,Chen L,Chen B,Li L,Chen M,Xing H M .2020 .Zafirlukast protects blood-brain barrier integrity from ischemic brain injury. Chem. Biol. Interact, 316 : 108915.